Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Phase I/II Study of VLS-1488 in Subjects With Advanced CancerChromosomal Instability, Chromosome Aberrations, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Genomic Instability, Head and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Urogenital Diseases, Urogenital Neoplasms, breast disorder, breast neoplasm, carcinoma, endometrium neoplasm, epithelial neoplasm, female reproductive system disorder, female reproductive system neoplasm, head and neck squamous cell carcinoma, neoplasm, ovarian carcinosarcoma, skin disorder, squamous cell carcinoma, triple-negative breast carcinoma, uterine carcinosarcoma, uterine disorderRecruitingPhase 1 / Phase 22025-11-04NCT05902988

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Volastra Therapeutics, Inc.2

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Community Health NetworkIndianapolisUnited States5
Froedtert & the Medical College of WisconsinMilwaukeeUnited States31
Hoag Memorial HospitalNewport BeachUnited States18
Johns Hopkins Sidney Kimmel Comprehensive Cancer CenterBaltimoreUnited States2
Kellogg Cancer CenterEvanstonUnited States1
M.D. Anderson Cancer CenterHoustonUnited States14
Memorial Sloan Kettering Cancer CenterNew YorkUnited States1000
START MidwestGrand RapidsUnited States79
The Christ HospitalCincinnatiUnited States81
University of Colorado Cancer CenterAuroraUnited States63
University of MichiganAnn ArborUnited States538
University of Southern CaliforniaLos AngelesUnited States110
Women & Infants HospitalProvidenceUnited States10
Yale Cancer CenterNew HavenUnited States21